Accurate assessment of LV function using the first automated 2D-border detection algorithm for small animals - evaluation and application to models of LV dysfunction by Grune, J. et al.
HOW I DO IT ARTICLE Open Access
Accurate assessment of LV function using
the first automated 2D-border detection
algorithm for small animals - evaluation
and application to models of LV
dysfunction
Jana Grune1,2, Daniel Ritter2,3, Kristin Kräker2,4,5,6,12, Kathleen Pappritz2,7, Niklas Beyhoff2,3, Till Schütte2,3,5,12,
Christiane Ott2,8, Cathleen John2,8, Sophie van Linthout2,7,9, Carsten Tschöpe2,7,9, Ralf Dechend2,4,5,6,10,
Dominik N. Muller2,4,5,6,12, Nadine Haase2,4,5,6,12, Tilman Grune2,8,11, Ulrich Kintscher2,3 and
Wolfgang M. Kuebler1,2,13*
Abstract
Echocardiography is the most commonly applied technique for non-invasive assessment of cardiac function in
small animals. Manual tracing of endocardial borders is time consuming and varies with operator experience.
Therefore, we aimed to evaluate a novel automated two-dimensional software algorithm (Auto2DE) for small
animals and compare it to the standard use of manual 2D-echocardiographic assessment (2DE). We hypothesized
that novel Auto2DE will provide rapid and robust data sets, which are in agreement with manually assessed data of
animals.
2DE and Auto2DE were carried out using a high-resolution imaging-system for small animals. First, validation
cohorts of mouse and rat cine loops were used to compare Auto2DE against 2DE. These data were stratified for
image quality by a blinded expert in small animal imaging. Second, we evaluated 2DE and Auto2DE in four mouse
models and four rat models with different cardiac pathologies.
Automated assessment of LV function by 2DE was faster than conventional 2DE analysis and independent of
operator experience levels. The accuracy of Auto2DE-assessed data in healthy mice was dependent on cine loop
quality, with excellent agreement between Auto2DE and 2DE in cine loops with adequate quality. Auto2DE allowed
for valid detection of impaired cardiac function in animal models with pronounced cardiac phenotypes, but yielded
poor performance in diabetic animal models independent of image quality.
Auto2DE represents a novel automated analysis tool for rapid assessment of LV function, which is suitable for data
acquisition in studies with good and very good echocardiographic image quality, but presents systematic problems
in specific pathologies.
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Introduction
Echocardiography is the standard of use for the assess-
ment of left ventricular (LV) function in clinical routine
and basic research [1, 2]. Despite recommendations for
the use of three-dimensional echocardiography (3DE)
[3], two-dimensional echocardiography (2DE) still pre-
sents a relatively inexpensive, straightforward and time
saving method for the non-invasive assessment of LV
function as compared to 3DE and gold-standard cardiac
magnetic resonance imaging (CMR) and is therefore
often the method of choice [1, 2]. Typically, 2DE analysis
in small animals is based on the traditional monoplane
Simpson’s method of discs where endocardial border
regions are traced in a single image plane, usually the max-
imum dimension of the LV [4]. The procedure of endocar-
dial border tracing has to be repeated in end-systolic and
end-diastolic frames to allow the calculation of e.g. LV
ejection fraction (EF), a key parameter for diagnosis, man-
agement and treatment of cardiac pathologies [2, 3, 5].
Despite the seeming simplicity of 2DE analysis, large inter-
individual variabilities have been reported for this analysis
in both humans and small animals [6–8]. Moreover, quanti-
tative analysis of 2DE is highly dependent on operator ex-
perience and analysis of imaging data requires a significant
investment of time, especially for basic research studies
with large n-numbers [9].
Required operator experience and time consumption,
the major drawbacks of conventional 2DE analysis, might
be overcome with the use of novel automated software
tools. Automated software approaches have been used
earlier in clinical research and demonstrated rapid and
reproducible assessment of LV function with very good
agreements between automated software tools and
manually assessed results [2, 9–12]. Advancements in
ultrasound technology recently also paved the way
for the first automated 2D-border detection algorithm
(Auto2DE, FUJIFILM VisualSonics, Toronto, Ontario,
Canada) for the assessment of LV systolic function in
small animals. Auto2DE represents a clinically proven
edge-matching algorithm trained with a library of over 200
expertly curated LV analysis traces. Cine loops of choice
are automatically tested against this library, resulting in the
generation of a potentially user-modifiable tracing of LV
endocardial borders across an automatically selected series
of frames (Fig. 1a). While the advantages of such a novel
automated algorithm for basic research cannot be over-
stressed, its usefulness critically depends on its ability to
yield valid and reproducible data and its ability for rapid
data analysis independent of observer experience.
To our knowledge, this automated software approach
for small animals has not been evaluated to date. In the
present study we therefore utilized novel Auto2DE for
the assessment of LV function and compared obtained
values with manually 2DE-assessed data in healthy and
diseased animals. We hypothesized that Auto2DE is able
to rapidly provide accurate data, which correlate well
with 2DE values. We also speculated that the strength of
this relationship is likely dependent on image quality,
which may limit Auto2DE performance in severe cardiac
pathologies.
Material and methods
All animal procedures were performed in accordance
with the German Law on Protection of Animals and
according to the European legislation (Directive 2010/
63/EU) and were approved by the local authorities
(Landesamt für Gesundheit und Soziales, Berlin, Germany).
Animals used in this study served as controls in on-
going projects or were partly already described in re-
cent publications (transverse aortic constriction (TAC),
Isoproterenol-induced subendocardial fibrosis (Fib) and a
double-transgenic rat model of heart failure with preserved
ejection fraction (HFpEF; dTGR cohorts)) [7, 13, 14].
Validation cohorts in mice and rats
Animals were kept under identical housing conditions (12
h light/dark cycle, standard diet ad libitum, 21 °C room
temperature) prior to echocardiographic assessment.
Echocardiographic data sets from 13 healthy male con-
trol mice (strain: Ncor1tm1Anh/J (the Jackson Laboratory,
JAX stock #017632) were used as murine validation
cohort. Each individual mouse was imaged fourfold at
the age of 8, 12, 15, and 18 weeks. From the resulting 52
echocardiographic data sets 2 were rated with image
quality Q4 (for details see Assessment of image
quality-section below) and therefore excluded from
further analysis, the remaining 50 data sets entered
further analysis.
For the rat validation cohort, a set of 14 echocardio-
graphic cine loops from 14 healthy rats (strain: sprague
dawley rat, Max-Delbrück Center; 7 and 18 weeks of
age) was used.
Cardiovascular disease models
For induction of type I diabetes mellitus (DM), male
Ncor1tm1Anh/J mice (8–9 weeks) were injected with
streptozotocin (50 mg/kg/d STZ, n = 12) or vehicle (Ctrl,
n = 14) for 5 consecutive days. Animals were starved
prior to STZ- or vehicle injections for 4 h. Blood glucose
levels were determined with a Contour XT glucose
meter (Bayer Health Care; Leverkusen, Germany). Echo-
cardiography and blood glucose measurements were
performed 12 weeks after DM induction.
As model of type II DM, homozygous BKS.Cg-m
+/+Leprdb/BomTac (db+/db+, n = 15) mice (Taconic;
Skensved, Denmark) carrying a leptin receptor mutation
were used. Heterozygous (db+/db−) littermates served as
controls (n = 7). At 20 weeks of age, echocardiography
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was performed and blood glucose levels were determined
by Accu-Chek Aviva® (Roche Diabetes Care Deutsch-
land GmbH; Mannheim, Germany) after 4 h fasting.
With respect to Table 2, values for heart weight (HW),
body weight (BW) and Heart-weight-to-body-weigh-
t-ratios (HW/BW) were reported at 24 weeks of age.
Subendocardial fibrosis was modeled as described previ-
ously by us [13, 15]. In brief, 6–8 weeks old male 129/Sv
mice (n = 9, Janvier Labs; LeGenest-Saint-Isle, France)
were injected s.c. with isoproterenol (Fib, 25mg/kg/d;
dissolved in saline) or vehicle (saline, n = 10) for four con-
secutive days. Echocardiographic examinations were per-
formed 12–13 days after the final treatment, and final
necropsy was performed on day 14.
Mechanical loading as a model of LV failure was
induced in male C57BL/6 J mice (8–9 weeks, n = 9)
by transverse aortic constriction (TAC) as previously
reported by us [7, 16]. SHAM-operated animals
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Fig. 1 Automated assessment of LV function in healthy mice and rats. a Exemplary cine loops +/− tracings by conventional 2DE and novel
Auto2DE in healthy mice and rats. b Mean tracing time for mouse and c rat cine loops by operators of distinct experience levels. Numbers in
brackets indicate numbers of tracings. d Average Auto2DE-assessed LV function parameters in comparison to standard 2DE-assessed data sets in
cohorts of 52 mouse cine loops and e 14 rat cine loops. Bold printed numbers indicate the percentage mean difference between Auto2DE and
2DE. Numbers in brackets indicate n-numbers
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without banding served as controls (n = 7). Echocar-
diography was performed 10 weeks after TAC or
SHAM-surgery, and final necropsy was performed
one day later.
Generation of the inducible transgenic rat model for
DM was described previously by us [17]. In brief, male
tetO-shIR rats (TetO, 18 weeks) received 2 mg/kg/d
doxycycline (DOX) via drinking water until blood glu-
cose levels reached 300–400 mg/dl (n = 10). Baseline
measurements of tetO-shIR served as controls (n = 10).
Afterwards, we administered 0.5 mg/kg/d DOX over an
entire period of 8 weeks. Echocardiographic image ac-
quisition was carried out 8 weeks after initial DM in-
duction. Same experimental protocol was performed
using age-matched hypertensive Ren-2 transgenic TGR
(mREN2)27 rats (mRen) [18] and a cross breeding of
them with tetO-shIR (TetO/mRen), suffering from the
metabolic syndrome.
The double-transgenic rat (dTGR) model of experimen-
tal HFpEF, a cross-breed of TGR(hRen)L10 J (female
breeder) and TGR(hAogen)L1623 (male breeder) (dTGR,
10% transcutol, 20% cremophor, 70% water n = 8) and
nontransgenic SD control rats (n = 5) were treated by oral
gavage once daily [14]. Treatment was started at the age
of 4 weeks until the end of the study. Echocardiographic
image acquisition was performed directly before euthan-
asia at week 6.5.
Echocardiographic image acquisition
Echocardiography was carried out as recently described
by us [7, 13, 14]. Briefly, we used ultra-high frequency lin-
ear array transducers (mice: MX400 18–38MHz, center
transmit: 30MHz, axial resolution: 50 μm; rats: MX250
13–24MHz, center transmit: 21MHz, axial resolution:
75 μm) coupled to a Vevo® 3100 (mice) or a Vevo® 2100
(rats) high-resolution Imaging System (all FUJIFILM
VisualSonics; Toronto, Ontario, Canada). Animals were
anesthetized with 3% isoflurane (Baxter International,
Deerfield, Illinois, USA) and fixed in supine position on a
heatpad at 37 °C (FUJIFILM VisualSonics, Toronto, On-
tario, Canada). Isoflurane concentrations were further re-
duced to a minimum of 1–2% to achieve constant and
comparable heart rates during image acquisition. B-Mode
cine loops were generated visualizing the maximum di-
mension of the LV from apex to base in a parasternal long
axis view. All acquired images were digitally stored in raw
format (DICOM) for further offline-analyses.
Analysis with conventional 2D-echocardiography
2DE analysis was performed using the semi-automated
LVtrace-Tool of the dedicated software package Vevo-
LAB Version 3.0 (FUJIFILM VisualSonics; Toronto,
Ontario, Canada), which is based on the monoplane
Simpson’s method of discs. Semi-automated 2DE
tracings were generated by manual selection of
end-diastolic and end-systolic dimension of the LV by
each observer. To avoid variations due to sinus cycle
length and respiration artifacts the observer reviewed
several cardiac cycles of a cine loop and selected a suit-
able cycle prior to the tracing. 2DE tracings followed the
endocardial border regions, covering the whole LV from
apex to base. All B-Mode cine loops were traced twice
with gold standard 2DE to account for interbeat variabil-
ity, and resulting values were averaged for the final 2DE
data set. Details regarding the assessment of tracing time
can be found in the Additional file 1.
Automated assessment of LV function
The same set of B-Mode cine loops was used for con-
ventional 2DE and novel Auto2DE analysis (Vevo Lab
Version 3.1.0 (Build 13,029), FUJIFILM VisualSonics;
Toronto, Ontario, Canada). 2DE tracings were carried
out prior to Auto2DE analysis, ensuring adequate blinding
of the manual evaluation. 2DE-derived tracings and data
were not visible to the operator performing Auto2DE. For
analysis of Auto2DE, B-Mode cine loops of the LV were
manually navigated to an R-wave of the simultaneously re-
corded electrocardiogram by visually running through the
cine loop. If this procedure was hampered by pathophysi-
ologic alterations of the electrocardiogram, the maximum
dimension of the LV was manually visualized by the obser-
ver. The automated tracing was realized by using the
AutoLV-tool of the VevoLab software (further referred to
as Auto2DE). The chosen image is automatically tested
against a library to produce a tracing of the LV endocar-
dial borders across a series of frames. The tool was
developed by adapting the clinically accepted modified
Simpson’s monoplane method of disks approach for LV
analysis. Clicking the AutoLV-button in the measurement
panel automatically produces a tracing of the LV endocar-
dial border on each frame from the starting R-wave
(diastole) forward to the next P-wave (systole). Hence, au-
tomated analysis of the same frame twice, would result in
identical values of cardiac function parameters, guarantee-
ing observer-independence. To account for interbeat
variability, all B-Mode cine loops were traced twice with
Auto2DE, choosing two different frames for analysis. The
resulting values were subsequently averaged in the final
Auto2DE data set.
Assessment of image quality
Image quality was classified based on visibility of seg-
ments and endocardial borders as Q1 (good), Q2 (fair),
Q3 (poor), or Q4 (insufficient). Cine loops with Q4 were
excluded from all further analysis. The classification of
image quality was graded by an expert in small animal
echocardiography as follows: Q1 = clearly delineated
endocardial border regions and all segments clearly
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visible, no apex foreshortening; Q2 = slightly diffuse
endocardial visualization, occasional minor rib shadows
or artifacts in apex or base regions; Q3 = diffuse endo-
cardial border delineation combined with moderate arti-
facts or rib shadows or apex foreshortening; Q4 =
insufficient endocardial visualization or one or more seg-
ments covered by artifacts or rib shadows.
Statistics
All analyses were done using Prism 7 software (Graph-
Pad Software, La Jolla, CA). Results are shown as mean
± standard error of the mean (SEM) with/without indi-
vidual scatters. Statistical analyses were performed using
one-way-ANOVA for multiple comparisons followed by
Uncorrected Fisher’s LSD posttest. Correlation of vari-
ables of diseased cohorts was tested using Pearson’s cor-
relation coefficient (r). Correlation between methods
was defined as follows: r > .8 very good, r > .6 good, r > .4
moderate and r < .4 poor. A p-value of <.05 was assumed
as statistically significant. 2DE and Auto2DE were com-
pared by Bland-Altman plots and results expressed as
bias and limits of agreement (LOA). Post-hoc power
analysis was computed based on effect size, sample
size and type I error α, using the G*Power 3.1.9.4 free-
ware tool (Heinrich Heine University, Duesseldorf,
Germany).
Results
Automated assessment of LV function is faster than
conventional 2DE analysis
One of the major benefits to be expected from auto-
mated software algorithms is time effectiveness. To this
end, we compared the average time required for LV trac-
ings with conventional 2DE from observers with distinct
experience levels and novel Auto2DE in mice and rats
(Fig. 1b, c). Tracing times for rat cine loops were con-
sistently shorter than tracing times in mice, independent
of experience levels. For both rats and mice, observer
experience level had expectedly a strong effect on tra-
cing time, with less trained observers requiring longer
tracing times. Direct comparison of both software tools
demonstrated that mean tracing times of novel Auto2DE
were 6.5–7.5 fold faster than the fastest observer and
18–46 fold faster than the slowest observers for each
species. To assess accuracy of Auto2DE, we analyzed
data sets from 52 healthy mouse cine loops and 14
healthy rat cine loops (validation cohorts) with both
software tools and compared average values for cardiac
function parameters in spider plots (Fig. 1d, e), which
revealed excellent agreement between 2DE and conven-
tional Auto2DE in mice (Fig. 1d). LV function patterns
of rat cine loops shared main characteristics, however,
absolute values differed, especially when focusing on
absolute end-systolic volume (ESV) and end-diastolic
volume (EDV) and the resulting relative measure EF. A
post-hoc power analysis regarding both validation co-
horts can be found in the Additional file 1.
The accuracy of Auto2DE-assessed data is dependent on
cine loop quality
To investigate the degree to which image quality affects
the performance of Auto2DE analysis, cine loops of the
murine validation cohort were graded into four distinct
quality levels (Q1 - good, Q2 - fair, Q3 - poor, or Q4 -
insufficient) by an expert in small animal echocardiog-
raphy (Fig. 2a). Two cine loops showed inferior image
quality (Q4) due to poor endocardial border delineation
or segment visibility and were excluded from further
analyses. Exemplary images of quality levels and corre-
sponding manual and automated tracings indicate the
increasing challenge of endocardial border tracing with
decreasing image quality (Fig. 2b). Next, we correlated
values derived from both methods and calculated the
correlation coefficient for the stratified data sets (Table 1,
Fig. 2c). The results were in line with the exemplary
tracings in that correlation between manual and auto-
mated tracings decreased as a function of image quality.
For example, for Q1-stratified cine loops, all LV function
parameters showed good to very good correlations be-
tween both methods (Table 1). Correlation coefficients
decreased in Q2 and even further in Q3 stratified im-
ages, indicating that poor image quality caused enhanced
variabilities regarding cardiac function analysis between
both techniques (Fig. 2c). In contrast, correlation coeffi-
cients for EDV remained stable independent of image
quality. However, correlations were still best for cine
loops of Q1 stratified data.
As a next step, we displayed data from both analysis
tools as Bland-Altman plots to calculate bias and LOA
(Limits of Agreement) (Table 1, Fig. 2d). As compared
to mean absolute values (Fig. 1d) bias levels were small
and largely independent from image quality, indicating
the absence of systematic errors. LOA levels, however,
increased with poorer image quality. This is again exem-
plary shown for the clinically important metrics EF and
EDV (Fig. 2d).
Auto2DE performance is accurate in severe pathologic
cardiac phenotypes
To test whether automated tracing is suitable to de-
tect pathologic alterations in cardiac performance, we
applied Auto2DE in small animal models of distinct
cardiac pathologies. Physiological validation of the
phenotype of individual models including mean values
of echocardiographic data are shown in Table 2, and
Additional file 1: Tables S3-S4, but will not be exten-
sively discussed here.
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We investigated four mouse models (STZ: Type I DM,
db+/db+: Type II DM, Fib: subendocardial fibrosis, TAC:
LV failure) and four rat models (TetO: genetically-induced
DM, mRen: hypertension, TetO/mRen: metabolic syn-
drome, dTGR: HFpEF) with 2DE and novel Auto2DE
and correlated the obtained data sets. Color-coded
heat maps of correlation coefficients and corresponding
bar graphs of averaged correlation coefficient from all
seven cardiac function parameters (ESV, EDV, SV (stroke
volume), EF, FS (fractional shortening), CO (cardiac
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Table 1 Validity of automated tracings is dependent on image quality
Pearson’s r 95% CI p-value Equation Bias LOA Significance of Bias
Q1 (n = 16) EF (%) .67* .26 to .88 .0044 Y = 0.8312x + 6.223 −2.14 −15.7 to 11.4 n.s.
FS (%) .77* .44 to .92 .0005 Y = 2.082x-15.3 −1.20 −8.9 to 6.4 n.s.
EDV (μl) .87* .66 to .95 <.0001 Y = 0.8465x + 6.08 −4.85 −17.4 to 7.7 n.s.
ESV (μl) .73* .38 to .90 .0012 Y = 0.8159x + 5.644 −1.05 −15.6 to 13.5 n.s.
SV (μl) .88* .68 to .96 <.0001 Y = 0.9732x-2.87 −3.81 −10.8 to 3.2 n.s.
CO (μl) .88* .68 to .96 <.0001 Y = 0.9543x-1.024 −1.71 −4.7 to 1.3 n.s.
HR (bpm) .99* .96 to 1.0 <.0001 Y = 0.01201x + 7.861 2.73 −9.2 to 14.6 n.s.
Q2 (n = 21) EF (%) .52* .12 to .78 .015 Y = 0.6419x + 12.26 −5.68 −21.4 to 10.1 n.s.
FS (%) .24 −.22 to .61 .2977 Y = 0.2597x + 7.213 −2.21 −9.2 to 4.8 n.s.
EDV (μl) .76* .49 to .90 <.0001 Y = 0.7203x + 18.6 −0.30 −19.5 to 18.9 n.s.
ESV (μl) .60* .23 to .82 .0039 Y = 0.6607x + 14.98 3.61 −10.9 to 18.1 n.s.
SV (μl) .74* .45 to .88 .0001 Y = 0.7098x + 5.966 −3.91 −17.0 to 9.6 n.s.
CO (μl) .77* .50 to .90 <.0001 Y = 0.7843x + 1.646 −1.64 −7.4 to 4.1 n.s.
HR (bpm) .92* .80 to .97 <.0001 Y = 0.04046x-20.08 −1.91 −27.8 to 23.9 n.s.
Q3 (n = 13) EF (%) .33 −.27 to .75 .2726 Y = 0.3706x + 27.93 −5.60 −27.1 to 15.9 n.s.
FS (%) .56* .02 to .85 .0452 Y = 0.9746x-2.26 −2.60 −12.9 to 7.7 n.s.
EDV (μl) .76* .35 to .92 .0028 Y = 0.7182x + 16.49 −0.31 −19.0 to 18.4 n.s.
ESV (μl) .64* .15 to .88 .0175 Y = 0.734x + 10.66 3.13 −14.1 to 20.4 n.s.
SV (μl) .27 −.33 to .72 .3687 Y = 0.2637x + 19.62 −3.44 −19.7 to 12.8 n.s.
CO (μl) .27 −.33 to .71 .3757 Y = 0.2304x + 9.395 −1.80 −8.5 to 4.9 n.s.
HR (bpm) .92* .76 to .98 <.0001 Y = -0.08216x + 43 4.76 −26.0 to 35.5 n.s.
ESV End-Systolic Volume, EDV End-diastolic Volume, SV Stroke Volume, EF Ejection Fraction, FS Fractional Shortening, CO Cardiac Output, HR Heart Rate, LOA Limits
of Agreement. *Data in bold are statistically significant
Table 2 Phenotypic characteristics of pathophysiological small animal models
Species Modell Strain Age (wks) HW (mg) BW (g) HW/ BW-ratio Blood Glucose (mg/dl) Other
Mouse Ctrl Ncor1tm1Anh/J 20 150.5 ± 10.1 (n = 4) 33.1 ± 2.3 4.46 ± 0.1 (n = 4) 163 ± 15 –
Type I DM Ncor1tm1Anh/J 20 141.5 ± 17.7 (n = 2) 28.3 ± 2.6 5.34 ± 0.2 (n = 2) 537 ± 101 –
Ctrl db/db+ 20 158.2 ± 2.6 32.2 ± 0.6 4.92 ± 0.1 146 ± 23.9 –
Type II DM db+/db+ 20 124.8 ± 1.9 30.4 ± 1.7 3.88 ± 0.2 514 ± 68.6 –
Ctrl 129/Sv 8–10 113.7 ± 2.8a 26.8 ± 1.7a 4.24 ± 0.1a 156 ± 8a –
Iso 129/Sv 8–10 109.3 ± 2.6a 26.6 ± 1.8a 4.11 ± 0.1a 145 ± 6a –
Ctrl C57BL/6J 18–19 123.0 ± 8.3 28.0 ± 0.3 4.40 ± 0.1 192.7 Gradient Pb
±24.7 −2.17 ± 1.1
TAC C57BL/6J 18–19 160.3 ± 29.1 28.9 ± 0.3 5.72 ± 0.3 192.2 Gradient Pb
±40.6 32.22 ± 3.2
Rats Ctrl tetO-shIR 18 – 427 ± 6.8 – 108.5 ± 1.5 –
TetO tetO-shIR 26 – 404 ± 5.3 – 427.5 ± 23 –
mRen mRen27 26 – 438 ± 12.7 – 117 ± 2.5 –
TetO/mRen mRen27/tetO-shIR 26 – 345 ± 12.9 – 309 ± 25.1 –
Ctrl Sprague Dawley 7 – 180 ± 7.4 – – –
dTGR female:TGR(hRen)L10 J 7 – 170 ± 2.8 – – –
male:TGR(hAogen)L162
3
HW Heart weight, BW Body weight, HW/BW-ratio heart weight/Bodyweight-ratio. aData published previously in [13]. bData published previously in [7]. Gradient P assessing
the degree of aortic stenosis was calculated from velocity parameters 10weeks post-TAC as described previously [30, 31]. *Data in bold are statistically significant
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output), HR (heart rate)) or from all four animal
models, respectively, reflect the suitability of Auto2DE
in individual animal models or with respect to meas-
urement of individual cardiac parameters, respectively
(Fig. 3a, b).
Surprisingly, similar patterns of correlations emerged
for individual animal models in both species, in that dia-
betic models (mice: STZ, db+/db+; rats: TetO) yielded
the poorest cumulative correlation. In contrast and
against our original hypothesis that strong phenotypes
would be less suitable for an automated analysis algo-
rithm, in both species models with pronounced cardiac
phenotypes and markedly impaired LV function showed
good to very good correlations (TAC: r = .86; TetO/
mRen: r = .64) (Fig. 3a, b). Individual LV function param-
eters also differed with respect to their accurate assess-
ment by Auto2DE. Heart rate was by far the parameter
with best agreement between methods in both species
(mice: r = .93; rats: r = .77). In mice the relative metrics
SV and CO correlated well between software tools. In
rats, analysis of LV dimensions yielded good cumulative
correlations for the absolute volumes ESV and EDV, while
correlation was poor for relative metrics SV and EF.
A closer look at the method comparison in pronounced
cardiac pathologies revealed that Auto2DE is in general
suitable to detect strong phenotypes, defined as impaired
LV function in terms of reduced EF accompanied by
significant cardiac remodeling (e.g. endocardial fibrosis,
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Fig. 3 Correlation analysis of 2DE and Auto2DE-assessed data in cardio-pathophysiological conditions. a Color-coded heat map of correlation
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Fig. 4 Method comparison of Auto2DE and 2DE in pathologies with pronounced alterations of LV function. a Mean EF- and b CO-difference
between SHAM-mice and TAC-mice assessed with novel Auto2DE and 2DE. Bland-Altman analysis was stratified by healthy and diseased mice.
c Mean EF- and d CO-difference between Ctrl-rats and TetO/mRen-rats assessed with novel Auto2DE and 2DE. Bland-Altman analysis was
stratified by healthy and diseased rats. Numbers in brackets indicate the n-numbers. LOA: Limits of Agreement. *p < .05 vs. corresponding
control-group analyzed with the same imaging technique
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inflammation, hypertrophy). However, when directly com-
paring TAC-mice to their corresponding SHAM-controls,
Auto2DE failed to detect significant reduced EF, while
conventional 2DE reliably detected the expected decreased
EF (Fig. 4a). The concomitant decrease in the clinically
relevant parameter CO in TAC-mice as compared to
SHAM-controls was detected with statistical significance
by both techniques, indicating the general capacity of
Auto2DE for detection of impaired cardiac perform-
ance (Fig. 4b). Bland-Altman analysis of TAC mice and
SHAM-controls showed very good agreement and
minimal bias between automated and semi-automated
software tools and no differences in the analysis of
healthy or diseased mice (Fig. 4b, c). These results were
corroborated by data from TetO/mRen-rats as a model of
metabolic syndrome (Fig. 4c, d). Both Auto2DE and con-
ventional 2DE detected a highly significant reduced EF and
CO in diseased as compared to control rats (Fig. 4c).
Poor image quality is not the cause for poor performance
of Auto2DE in diabetic animal models
In contrast to our original hypothesis that pronounced
cardiac phenotypes would in general be less suitable for
automated analysis tools, we found Auto2DE analysis to
be specifically hampered in three diabetic animal models.
Based on the impact of image quality on Auto2DE per-
formance shown previously in this study, we speculated
that diabetic cardiomyopathy may result in poor image
quality per se. To test this notion, we compared mean
image quality of diabetic animals and their corresponding
healthy controls of the same study (Fig. 5a). While individ-
ual studies differed in averaged image quality, no differ-
ences in image quality were detected between healthy and
diabetic animals, indicating that diabetic conditions did
not worsen image quality per se (Fig. 5a, b). Next, we cal-
culated the mean difference between Auto2DE and 2DE
for the parameters EF and CO for healthy and diseased
animals stratified by image quality, to probe whether
Auto2DE is similarly image quality-dependent in diabetic
conditions as previously shown for healthy animals (vide
supra) (Fig. 5 c, d). Mean differences and standard devia-
tions between Auto2DE and 2DE increased as a function
of quality level in healthy controls, corroborating the re-
sults from the murine validation cohort. A similar pattern
was observed in diabetic animals, suggesting that poor
image quality had similar effects on the performance of
Auto2DE in both healthy and diseased animals. Taken
together, these findings exclude poor image quality as the
predominant cause for the poor performance of Auto2DE
in diabetic animal models.
Discussion
In the present study, we evaluated a novel automatic soft-
ware tool for LV function assessment against the manual
2DE standard of use method. Our results revealed that (1)
data analysis with Auto2DE is rapid, straightforward and
independent of observer experience levels, (2) Auto2DE-
assessed data correlated with manually assessed 2DE data
with negligible mean differences or bias and within reason-
able LOAs in healthy mice, yet less so in rats, (3) correla-
tions between both techniques were dependent on image
quality, indicating that Auto2DE performance decreases as
a function of image quality, (4) pronounced cardiac
phenotypes showed in general good agreement be-
tween methods, with the notable exception of diabetic
animal models which seem less suitable for analysis
with Auto2DE.
A major advantage of novel Auto2DE is the independ-
ence of observer experience level and hence, a small
intra- and interobserver variability, which became evi-
dent when tracing the same cardiac cycle twice with
Auto2DE, beginning with the same frame, always leads
to the same data set (data not shown). In contrast, ob-
server variabilities and operator experience levels are
known as major drawback of manually analyzed echo-
cardiographic data sets [19–21]. The requirement for
extensive training, and the remaining time-consuming
task of manual tracing have fuelled interest within the
basic research community into automated software ap-
proaches for the assessment of echocardiographic data
that can rapidly generate data sets with high reproduci-
bility and independent of observer experience. However,
there seem to be differences regarding the tracing with
Auto2DE between mice and rats, since absolute values
of Auto2DE-assessed LV function parameters differed
more in rats compared to mice. Due to the rat’s larger
size, physiological noise originating from cardiac and re-
spiratory motion is larger as compared to mice. As cardio-
respiratory noise is well known to cause severe artifacts,
such an effect may hamper the proper analysis of rat cine
loops by Auto2DE [22–24]. Another explanation for this
finding could be an underrepresentation of rats among
the 200 expertly curated LV analysis traces used to train
the Auto2DE algorithm (which is unknown as the original
tracing library is not public domain).
Yet, automated analyses may be critically hampered by
observer-independent factors such as poor image quality;
however, this problem applies equally to conventional
analyses. Previous studies have highlighted the impact of
image quality on the reliability of the produced data for
both manually assessed 2DE [25] or 3DE [26] data sets.
It is thus little surprising that also in automated approaches
image quality influences analytical performance. The rele-
vance of this finding should be emphasized, as image qual-
ity of the data set thus emerges as a pivotal factor
contributing to future decision making regarding the choice
of analysis tools utilized in small animal studies. In the
present study and in line with clinical automated software
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approaches, we decided to include all cine loops with
adequate quality for Auto2DE and 2DE and performed no
further preselection based on image quality in order to
realistically mimic experimental routines of animal studies
[10, 11]. Future studies may consider possible exclusion
criteria for cine loops with poor image quality to increase
reliability of Auto2DE when utilized in murine studies.
We originally hypothesized that phenotypes with se-
verely altered cardiac function may not be suitable for
Auto2DE analysis, as such pathologies may be associated
with poor image quality. Conversely, we observed that
pronounced cardiac phenotypes, namely a mouse model
of LV failure and a rat model of metabolic syndrome,
were suitable for the analysis with Auto2DE and showed
the best correlation with 2DE-derived data of all tested
animal models. In contrast, subtle alterations of cardiac
phenotypes, caused by DM, fibrosis or hypertension
showed less convincing results, when assessed with
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Auto2DE. Along similar lines, Auto2DE was not able to
show the expected significant reduction of EF in TAC-mice
as compared to SHAM-controls, pointing towards a lower
sensitivity of novel Auto2DE compared to manual 2DE.
The observed results underline the importance of sen-
sitivity in diagnostic imaging technologies with echo-
cardiographic results building the basis for clinical
decision-making and research interpretation, respect-
ively. Notably, none of the clinical approaches with
automated 2DE software tools have yet addressed the
question whether automated software tools may be
less or more suitable for individual pathologies despite
their use in individual clinical studies [11, 12, 27]. We
conclude from our data that the current version of the
Auto2DE software tool is sufficiently sensitive for
quantitative diagnosis of pronounced cardiac patholo-
gies and associated severe alterations in cardiac func-
tion, while its usefulness for the analysis of early
cardiac damage or subclinical disease stages such as
seen in diabetic animal models is still limited.
Clinical approaches of automated software tools dem-
onstrated very good agreement rates for the clinically
relevant parameter EF, with partially similar or better ac-
curacy as established control methods [9, 11, 12]. In the
present study, we can only speculate as to the reasons
for the poor agreement rates of EDV and ESV in mice.
One confounding factor might be the choice of two
murine diabetic models, namely STZ and db+/db+,
which demonstrated poor outcome in correlation ana-
lysis of all cardiac function parameters. When excluding
diabetic mouse models (just Fib and TAC) from the cu-
mulative correlation analysis, ESV and EDV parameters
reach good correlations, which are comparable to SV
and EF calculated correlations. This murine effect was
replicated in a diabetic rat model (TetO) which again
showed the worst outcome in correlation analysis of all
included animal models. As such, our data suggest that
the safe and valid use of automated software tools is spe-
cifically hampered in diabetic disease conditions. Not-
ably, both type I and II DM cause pathologic heart rate
variabilities in mice [28, 29]. In line with this notion,
Stables and colleagues reported previously a relative re-
duction of sympathetic control of HR for type I DM
STZ model and an altered circadian rhythm of sympa-
thetic HR-control for db+/db+-mice [29]. Notably, our
own data yield a poor correlation of HR measured with
Auto2DE as compared to manually assessed HR in STZ
and TetO animal models, yet not in animal models of
other cardiac pathologies. HRs measured via an electro-
physiological signal, i.e. R-wave (end-diastole) and P-wave
(end-systole), are the basis for the novel Auto2DE tech-
nique, which automatically searches for the end-systolic
frame based on the electrocardiography (ECG)-signal. In
contrast, experienced observers often visualize primarily
the maximum and minimum dimension of the LV in the
B-mode cine loop and use the ECG-signal only in a sec-
ondary manner for the manual analysis of LV function.
Analysis of B-mode images by the automated software
tool or manual tracing of the observer is therefore based
on different parameters (ECG-signal vs. B-mode image).
When we compared the amount of frames analyzed by au-
tomated and manual tracings, we realized that the number
of analyzed frames sometimes differed between both tech-
niques (data not shown), possibly leading to poor outcome
of Auto2DE in diabetic animal models. Moreover, the au-
tomated algorithm was probably originally not trained
with cine loops from diabetic animals, therefore hamper-
ing the analysis of the same (information was not access-
ible from the company). Even if we cannot prove this
hypothesis with the available data sets, a relationship of
the type of cardiac pathology and suitability for the ana-
lysis with Auto2DE seems to exist.
Our study has some limitations, which should be taken
into account when interpreting the presented data set.
First, mouse and rat models analyzed with 2DE and novel
Auto2DE were of different age. The possibility that aging
as a pathophysiological process itself could have had im-
pact on cardiac performance was not investigated and
cannot be ruled out in our methodological approach to
compare both aforementioned imaging modalities. Future
studies may address whether Auto2DE is suitable for the
analysis of age-associated cardiac function decline. Sec-
ond, while animals were positioned on a 37 °C heatpad
during image acquisition we did not monitor body
temperature directly. Therefore, we cannot fully exclude
that variations in body temperature had potential con-
founding effects on the assessment of cardiac performance
in the present study. In the present study, we opted to use
the MX400 linear array transducer due to its superior per-
formance in tissue penetration for the echocardiographic
examination of mice cohorts, which however comes at the
cost of a slightly lower spatial resolution as compared to
the MX550D linear array transducer (Visualsonics). Fur-
thermore, post-hoc power analysis demonstrated that the
sample size in the rat validation cohort was not sufficient
to detect differences between 2DE and Auto2DE for the
relative metrics EF and FS. Ongoing studies using larger
sample sizes will thus be required to verify that the tested
echocardiographic modalities yield similar results in rats.
Lastly, it should be emphasized that correlation analyses
reflect relationships rather than agreement between two
imaging modalities. The latter was exemplarily addressed
in detail by Bland & Altman analyses for two cardiovascu-
lar disease models and two cardiac function parameters.
Conclusion
Fully automated assessment of LV function in small ani-
mals by Auto2DE is feasible, fast, and provides precise
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results comparable to manually assessed data in healthy
mice and, albeit to a lesser degree, in rats. Auto2DE
sensitively diagnoses severe cardiac pathologies with
pronounced alterations of LV function in small animals.
However, automated analysis by Auto2DE is hampered
by poor image quality and in pathologies with subtle al-
tered LV function such as diabetic cardiomyopathies.
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